Current Effective Therapeutics in Management of COVID-19

The current pandemic due to the SARS-CoV-2 virus has caused irreparable damage globally. High importance is placed on defining current therapeutics for Coronavirus Disease 2019 (COVID-19). In this review, we discuss the evidence from pivotal trials that led to the approval of effective therapeutics...

Descripción completa

Detalles Bibliográficos
Autores principales: Atluri, Kavya, Aimlin, Iris, Arora, Shitij
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9267414/
https://www.ncbi.nlm.nih.gov/pubmed/35807123
http://dx.doi.org/10.3390/jcm11133838
_version_ 1784743713609613312
author Atluri, Kavya
Aimlin, Iris
Arora, Shitij
author_facet Atluri, Kavya
Aimlin, Iris
Arora, Shitij
author_sort Atluri, Kavya
collection PubMed
description The current pandemic due to the SARS-CoV-2 virus has caused irreparable damage globally. High importance is placed on defining current therapeutics for Coronavirus Disease 2019 (COVID-19). In this review, we discuss the evidence from pivotal trials that led to the approval of effective therapeutics in the treatment and prevention of COVID-19. We categorize them as effective outpatient and inpatient management strategies The review also attempts to contextualize the efficacy of therapeutics to the emerging variants. Vaccines, which remain the most effective prevention against hospitalization and deaths is not included in this review.
format Online
Article
Text
id pubmed-9267414
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-92674142022-07-09 Current Effective Therapeutics in Management of COVID-19 Atluri, Kavya Aimlin, Iris Arora, Shitij J Clin Med Review The current pandemic due to the SARS-CoV-2 virus has caused irreparable damage globally. High importance is placed on defining current therapeutics for Coronavirus Disease 2019 (COVID-19). In this review, we discuss the evidence from pivotal trials that led to the approval of effective therapeutics in the treatment and prevention of COVID-19. We categorize them as effective outpatient and inpatient management strategies The review also attempts to contextualize the efficacy of therapeutics to the emerging variants. Vaccines, which remain the most effective prevention against hospitalization and deaths is not included in this review. MDPI 2022-07-01 /pmc/articles/PMC9267414/ /pubmed/35807123 http://dx.doi.org/10.3390/jcm11133838 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Atluri, Kavya
Aimlin, Iris
Arora, Shitij
Current Effective Therapeutics in Management of COVID-19
title Current Effective Therapeutics in Management of COVID-19
title_full Current Effective Therapeutics in Management of COVID-19
title_fullStr Current Effective Therapeutics in Management of COVID-19
title_full_unstemmed Current Effective Therapeutics in Management of COVID-19
title_short Current Effective Therapeutics in Management of COVID-19
title_sort current effective therapeutics in management of covid-19
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9267414/
https://www.ncbi.nlm.nih.gov/pubmed/35807123
http://dx.doi.org/10.3390/jcm11133838
work_keys_str_mv AT atlurikavya currenteffectivetherapeuticsinmanagementofcovid19
AT aimliniris currenteffectivetherapeuticsinmanagementofcovid19
AT arorashitij currenteffectivetherapeuticsinmanagementofcovid19

Ejemplares similares